Tag Archives: scrutiny

Transparency by drug companies, scrutiny by journalists, vital in vaccine news

Pfizer’s chairman and CEO proclaimed in a Pfizer company news release: “Today is a great day for science and humanity.” In that PR news release – but only in that format – Pfizer announced early results of “a vaccine efficacy rate above 90%, at 7 days after the second dose.” That’s about all we know… Read More »

Theranos redux? Not really. But claim of a ‘simple’ test for breast cancer warrants scrutiny

Once again the lure of a “simple” test has made headlines. This time the catalyst was a news release issued by the UK’s National Cancer Research Institute. Its title: “Simple blood test for early detection of breast cancer.” In fact, no such test exists. As the body of the PR news release acknowledged, it’s an… Read More »